Holdings
Global X Aging Population ETF
As of May 31, 2026, Global X Aging Population ETF reported 84 positions worth US$81.6M. Largest: Novo Nordisk A/s Class B, Eli Lilly And Company and Edwards Lifesciences Corporation. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Novo Nordisk A/s Class B | 67,891 | US$3.11M | +36,361 | May 31, 2026 |
| Eli Lilly And Company | 2,652 | US$2.93M | −107 | May 31, 2026 |
| Edwards Lifesciences Corporation | 31,927 | US$2.76M | +2,056 | May 31, 2026 |
| Roche Holding Ltd | 6,234 | US$2.63M | −548 | May 31, 2026 |
| Abbvie Inc. | 11,869 | US$2.58M | +464 | May 31, 2026 |
| Welltower Inc. | 12,218 | US$2.51M | −2,461 | May 31, 2026 |
| Ventas, Inc. | 29,677 | US$2.51M | +4,113 | May 31, 2026 |
| Merck & Company, Inc. | 20,617 | US$2.45M | −4,760 | May 31, 2026 |
| Bristol-myers Squibb Company | 42,594 | US$2.44M | +4,928 | May 31, 2026 |
| Amgen Inc. | 7,123 | US$2.4M | −23 | May 31, 2026 |